A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer. Biomol Biomed [Internet]. 2025 Jan. 24 [cited 2025 Feb. 27];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11865